Select Bibliography

Filter by any of these (after searching):

CALGB-90203

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 5 items

Impact of therapy on genomics and transcriptomics in high-risk prostate cancer treated with neoadjuvant docetaxel and androgen deprivation therapy

Beltran, Himisha , Wyatt, Alexander W , Chedgy, Edmund C ... - - Clin Cancer Res - 2017

Manuscript - Secondary-not-in-original - Primary - GU - CALGB-90203

CALGB 90203 (Alliance): Radical Prostatectomy with or without neoadjuvant chemohormonal therapy in men with clinically localized, high risk prostate cancer

Eastham, J.A. , Heller, G. , Halabi, S. , Monk, J. P. , Beltran, H. ... - ASCO - J Clin Oncol - 2019

Abstract - Primary - Primary - GU - CALGB-90203

CALGB 90203 (Alliance): Radical Prostatectomy with or without neoadjuvant chemohormonal therapy in men with clinically localized, high risk prostate cancer.

Eastham, J.A. , Heller, G. , Halabi, S. , Monk, J. P. , Beltran, H. ... - AUA - Journal of Urology - 2019

Abstract - Primary - Primary - GU - CALGB-90203

Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer

Eastham, James A. , Heller, Glenn , Halabi, Susan ... - - J Clin Oncol - 2020

Manuscript - Primary - Primary - GU - CALGB-90203

Baseline testosterone levels in men with clinically localized high-risk prostate cancer treated with radical prostatectomy with or without neoadjuvant chemohormonal therapy (Alliance)

Eastham, James A. , Heller, Glenn , Hillman, David W. ... - - J Urol - 2021

Manuscript - Secondary-not-in-original - Primary - GU - CALGB-90203